Nonprofit · EIN 06-1619523
ALLIANCE FOR CANCER GENE THERAPY INC
Tax-exempt · STAMFORD, CT 06902
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| April 30, 2026 | 990 | $5,167,910 | $3,128,633 | $2,039,277 | $20,157,168 | $3,503,835 | $16,653,333 |
| April 30, 2025 | 990 | $3,103,520 | $5,355,546 | -$2,252,026 | $15,733,028 | $3,506,891 | $12,226,137 |
| April 30, 2024 | 990 | $9,059,178 | $1,966,204 | $7,092,974 | $15,042,870 | $919,115 | $14,123,755 |
| April 30, 2023 | 990 | $3,231,770 | $2,498,579 | $733,191 | $7,929,383 | $1,674,066 | $6,255,317 |
Financial details: 990 for the year ended April 30, 2026
Revenue
- Contributions, gifts and grants
- $3,511,245
- Program service revenue
- $134,973
- Investment income
- $1,340,486
- Royalties
- $181,206
- Net gain from sales of assets
- $880,130
- Other revenue
- $181,206
Expenses
- Grants and similar amounts paid
- $2,036,801
- Compensation of officers, directors and key employees
- $511,525
- Other salaries and wages
- $65,757
- Salaries, compensation and benefits (total)
- $631,083
- Professional fundraising fees
- $0
- Legal fees
- $861
- Travel
- $37,045
- Program services (functional)
- $2,673,605
- Management and general (functional)
- $53,874
- Fundraising (functional)
- $401,154
Balance sheet and other
- Total assets, start of year
- $15,733,028
- Total assets, end of year
- $20,157,168
- Total liabilities, end of year
- $3,503,835
- Net assets, end of year
- $16,653,333
- Publicly traded securities
- $13,660,537
- Net assets without donor restrictions
- $16,653,333
- Gross receipts
- $14,034,416
- Employees
- 3
- Volunteers
- 19
- Year formed
- 2001
- State of legal domicile
- CT
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended April 30, 2026, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| BARBARA LAVERY | CHIEF PROGRAM OFFICER Officer | 40 | $271,039 | $22,597 |
| KERI EISENBERG | CHIEF PHILANTHROPY OFFICER Key employee | 40 | $220,863 | $8,248 |
| KEVIN HONEYCUTT | CEO & PRESIDENT Trustee or director, Officer | 40 | $0 | $0 |
| JONATHAN DOCTOR | DIRECTOR (EFF 3/12/26) Trustee or director | 1 | $0 | $0 |
| MARC ENGELSGJERD MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DANIEL ENGLANDER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARIA FARDIS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PETER A GLICKLICH ESQ | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MICHAEL GREGORY | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CHAU Q KHUONG | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN LAHEY PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ALEXANDRA LANDES | DIRECTOR (THRU 6/20/25) Trustee or director | 1 | $0 | $0 |
| BRUCE L LEVINE PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN NEAMONITIS | DIRECTOR (EFF 3/12/26) Trustee or director | 1 | $0 | $0 |
| BARBARA NETTER | DIRECTOR, HONORARY CHAIRMAN Trustee or director | 6 | $0 | $0 |
7 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| CHEN SCHOR | DIRECTOR Trustee or director | 1 | $0 |
| JOHN C SITES JR | DIRECTOR Trustee or director | 1 | $0 |
| KLAUS R VEITINGER MD PHD | DIRECTOR Trustee or director | 1 | $0 |
| MARTIN E WINTER | DIRECTOR Trustee or director | 1 | $0 |
| H WILLIAM SMITH | VICE PRESIDENT, LEGAL & SECRETARY Officer | 2 | $0 |
| COLLEEN MAGGI | VICE PRESIDENT, TREAS (EFF 6/25) Officer | 2 | $0 |
| CHRISTINE HERMAN | VICE PRESIDENT, TREAS (THRU 5/25) Officer | 2 | $0 |
990 for the year ended April 30, 2025: 21 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| BARBARA LAVERY | CHIEF PROGRAM OFFICER Officer | 40 | $264,230 | $8,992 |
| KERI EISENBERG | CHIEF PHILANTHROPY OFFICER Key employee | 40 | $215,301 | $8,081 |
| KEVIN HONEYCUTT | CEO & PRESIDENT Trustee or director, Officer | 40 | $0 | $0 |
| MARC ENGELSGJERD MD | DIRECTOR (EFF 12/5/24) Trustee or director | 1 | $0 | $0 |
| DANIEL ENGLANDER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARIA FARDIS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PETER A GLICKLICH ESQ | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MICHAEL GREGORY | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CHAU Q KHUONG | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN LAHEY PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ALEXANDRA LANDES | DIRECTOR Trustee or director | 1 | $0 | $0 |
| BRUCE L LEVINE PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| BARBARA NETTER | DIRECTOR, HONORARY CHAIRMAN Trustee or director | 6 | $0 | $0 |
| CHEN SCHOR | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN C SITES JR | DIRECTOR Trustee or director | 1 | $0 | $0 |
| KLAUS R VEITINGER MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARTIN E WINTER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| GBOLA AMUSA | DIRECTOR (THRU 6/27/24) Trustee or director | 1 | $0 | $0 |
| THERESA BURGESS PHD | DIRECTOR (THRU 6/27/24) Trustee or director | 1 | $0 | $0 |
| H WILLIAM SMITH | VICE PRESIDENT, LEGAL & SECRETARY Officer | 2 | $0 | $0 |
| CHRISTINE HERMAN | VICE PRESIDENT, TREAS(THRU 5/31/25) Officer | 2 | $0 | $0 |
990 for the year ended April 30, 2024: 19 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| BARBARA LAVERY | CHIEF PROGRAM OFFICER Officer | 40 | $257,619 | $18,375 |
| KERI EISENBERG | CHIEF PHILANTHROPY OFFICER Key employee | 40 | $194,402 | $5,600 |
| BARBARA NETTER | HONORARY CHAIRMAN Trustee or director | 6 | $0 | $0 |
| KEVIN HONEYCUTT | PRESIDENT, CEO & DIRECTOR Trustee or director, Officer | 40 | $0 | $0 |
| GBOLA AMUSAMD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| TERESA BURGESS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DANIEL ENGLANDER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARIA FARDIS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PETER A GLICKLICH | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MICHAEL GREGORY | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CHAU KHUONG | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN L LAHEY PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ALEXANDRA LANDES | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CHEN SCHOR | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN C SITES JR | DIRECTOR Trustee or director | 1 | $0 | $0 |
| KLAUS VEITINGER MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARTIN WINTER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| H WILLIAM SMITH | VICE PRESIDENT, LEGAL, SEC Officer | 2 | $0 | $0 |
| CHRISTINE HERMAN | VICE PRESIDENT, TREASURER Officer | 2 | $0 | $0 |
990 for the year ended April 30, 2023: 18 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| BARBARA LAVERY | CHIEF PROGRAM OFFICER Officer | 40 | $235,943 | $18,748 |
| BARBARA NETTER | HONORARY CHAIRMAN Trustee or director | 6 | $0 | $0 |
| KEVIN HONEYCUTT | PRESIDENT, CEO & DIRECTOR Trustee or director, Officer | 40 | $0 | $0 |
| GBOLA AMUSAMD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| TERESA BURGESS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DANIEL ENGLANDER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARIA FARDIS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| PETER A GLICKLICH | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MICHAEL GREGORY | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CHAU KHUONG | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN L LAHEY PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ALEXANDRA LANDES | DIRECTOR Trustee or director | 1 | $0 | $0 |
| CHEN SCHOR | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN C SITES JR | DIRECTOR Trustee or director | 1 | $0 | $0 |
| KLAUS VEITINGER MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MARTIN WINTER | DIRECTOR Trustee or director | 1 | $0 | $0 |
| H WILLIAM SMITH | VICE PRESIDENT, LEGAL, SEC Officer | 2 | $0 | $0 |
| CHRISTINE HERMAN | VICE PRESIDENT, TREASURER Officer | 2 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 96 CUMMINGS POINT RD, STAMFORD, CT 06902-7919
- Principal officer (990 for 2025)
- KEVIN HONEYCUTT, 96 CUMMINGS POINT ROAD, STAMFORD, CT 06902
- Signed the 990
- KEVIN HONEYCUTT, CEO AND PRESIDENT
- Phone
- (203) 358-5055
- Website
- WWW.ACGTFOUNDATION.ORG
- Return prepared by
- EISNER ADVISORY GROUP LLC
Mission
ACGT SUPPORTS HIGH-RISK, HIGH-REWARD SCIENTIFIC RESEARCH TO DEVELOP CANCER THERAPEUTICS THAT USE THE BODY'S OWN CELLS AND GENES AS A LIVING MEDICINE. BY ACCELERATING THIS RESEARCH, ACGT IS HELPING TO ADVANCE THERAPIES THAT ARE SIGNIFICANTLY MORE EFFECTIVE AND LESS TOXIC THAN CURRENT CANCER TREATMENTS SUCH AS CHEMOTHERAPY AND RADIATION.
Program accomplishments
- IN FISCAL 4/30/26, ACGT FUNDED CLINICAL INVESTIGATOR GRANTS AWARDED TO INNOVATIVE SCIENTISTS CONDUCTING TRANSLATIONAL RESEARCH AT PREMIER ACADEMIC INSTITUTIONS IN THE U.S., EACH FOCUSING ON THE DEVELOPMENT OF CANCER CELL AND GENE THERAPIES FOR DIFFERENT CANCERS, INCLUDING PANCREATIC, PEDIATRIC, AND BRAIN CANCERS, AND CANCER METASTASIS. ACGT CONTINUED MULTI-YEAR COLLABORATIONS WITH MULTI-DISCIPLINARY 501(C)(3) ORGANIZATIONS FOCUSED ON CELL AND GENE THERAPY RESEARCH. ACGT FURTHER CONVENED ITS ANNUAL SCIENTIFIC SUMMIT AND ALSO INCREASED PUBLIC AWARENESS OF CELL AND GENE THERAPY RESEARCH THROUGH ACGT'S WEBSITE, SOCIAL MEDIA, AND IMPACT REPORTS.Expenses $2,673,605 · grants $2,036,801 · revenue $316,179
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in April, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | April 30, 2026 | September 15, 2026 | 990 on file |
| 2024 | April 30, 2025 | September 15, 2025 | 990 on file |
| 2023 | April 30, 2024 | September 16, 2024 | 990 on file |
IRS record
- EIN
- 06-1619523
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2001
- Accounting year ends
- April
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Philanthropy, voluntarism and grantmaking foundations (T30)
- Assets (IRS master file)
- $20,157,168
- Income (IRS master file)
- $14,034,416
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | April 2026 | $5,167,910 | $3,128,633 | $20,157,168 | XML |
| 990 | April 2025 | $3,103,520 | $5,355,546 | $15,733,028 | XML |
| 990 | April 2024 | $9,059,178 | $1,966,204 | $15,042,870 | XML |
| 990 | April 2023 | $3,231,770 | $2,498,579 | $7,929,383 | XML |
| 990 | April 2022 | $3,295,905 | $1,804,221 | $7,018,537 | IRS |
| 990 | April 2021 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 06-1619523).
Questions about ALLIANCE FOR CANCER GENE THERAPY INC
- What is the EIN of ALLIANCE FOR CANCER GENE THERAPY INC?
- The employer identification number (EIN) of ALLIANCE FOR CANCER GENE THERAPY INC is 06-1619523.
- Is ALLIANCE FOR CANCER GENE THERAPY INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2001.
- Are donations to ALLIANCE FOR CANCER GENE THERAPY INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does ALLIANCE FOR CANCER GENE THERAPY INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of ALLIANCE FOR CANCER GENE THERAPY INC due?
- The return for tax year 2026 (the year ending April 30, 2027) is due September 15, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did ALLIANCE FOR CANCER GENE THERAPY INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended April 2026.
- Who is the principal officer of ALLIANCE FOR CANCER GENE THERAPY INC?
- The 990 for the year ended April 30, 2026 names KEVIN HONEYCUTT.
- Who are the officers and directors of ALLIANCE FOR CANCER GENE THERAPY INC?
- The 990 for the year ended April 30, 2026 lists 22 people; 2 received compensation from the organization, the highest $271,039 (BARBARA LAVERY, CHIEF PROGRAM OFFICER).
- How much revenue does ALLIANCE FOR CANCER GENE THERAPY INC have?
- On its 990 for the year ended April 30, 2026 it reported revenue of $5,167,910, expenses of $3,128,633 and total assets of $20,157,168 at year end.
Other nonprofits in STAMFORD
- STEVEN & ALEXANDRA COHEN FOUNDATION INC EIN 06-1627638 · last filed 990-PF for 2024
- JOHN AND MARY PAPPAJOHN FAMILY FOUNDATION EIN 81-4941931 · last filed 990-PF for 2024
- COHEN VETERANS NETWORK INC EIN 47-3950655 · last filed 990-PF for 2024
- HALVORSEN FAMILY FOUNDATION EIN 06-1603158 · last filed 990-PF for 2025
- DELOITTE FOUNDATION EIN 13-6400341 · last filed 990 for 2025
- FRED AND DONNA NIVES FOUNDATION EIN 13-7390002 · last filed 990-PF for 2025
- SYNCHRONY FOUNDATION EIN 82-2935158 · last filed 990-PF for 2025
- BROTHERS BROOK FOUNDATION EIN 46-1509070 · last filed 990-PF for 2025
All nonprofits in STAMFORD · Connecticut · Philanthropy, voluntarism and grantmaking foundations